These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Davis AA; Leyns CEG; Holtzman DM Annu Rev Cell Dev Biol; 2018 Oct; 34():545-568. PubMed ID: 30044648 [TBL] [Abstract][Full Text] [Related]
5. Effects of curcumin on mitochondria in neurodegenerative diseases. Bagheri H; Ghasemi F; Barreto GE; Rafiee R; Sathyapalan T; Sahebkar A Biofactors; 2020 Jan; 46(1):5-20. PubMed ID: 31580521 [TBL] [Abstract][Full Text] [Related]
7. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge]. Hauw JJ; Hausser-Hauw C; Duyckaerts C Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802 [TBL] [Abstract][Full Text] [Related]
8. Interface between tauopathies and synucleinopathies: a tale of two proteins. Galpern WR; Lang AE Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609 [TBL] [Abstract][Full Text] [Related]
9. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration. Ling H Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904 [TBL] [Abstract][Full Text] [Related]
10. Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders. Armstrong RA; Cairns NJ J Neural Transm (Vienna); 2015 Oct; 122(10):1355-67. PubMed ID: 25929331 [TBL] [Abstract][Full Text] [Related]
11. Pathology vs pathogenesis: Rationale and pitfalls in the clinicopathology model of neurodegeneration. Donadio V; Sturchio A; Rizzo G; Abu Rumeileh S; Liguori R; Espay AJ Handb Clin Neurol; 2023; 192():35-55. PubMed ID: 36796947 [TBL] [Abstract][Full Text] [Related]
12. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Jellinger KA Neurodegener Dis; 2008; 5(3-4):118-21. PubMed ID: 18322367 [TBL] [Abstract][Full Text] [Related]
13. [Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology]. Shelkovnikova TA; Kulikova AA; Tsvetkov FO; Peters O; Bachurin SO; Bukhman VL; Ninkina NN Mol Biol (Mosk); 2012; 46(3):402-15. PubMed ID: 22888630 [TBL] [Abstract][Full Text] [Related]
14. Dendritic Spine Pathology in Neurodegenerative Diseases. Herms J; Dorostkar MM Annu Rev Pathol; 2016 May; 11():221-50. PubMed ID: 26907528 [TBL] [Abstract][Full Text] [Related]
15. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Williams DR Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643 [TBL] [Abstract][Full Text] [Related]
17. The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases. Pichla M; Bartosz G; Sadowska-Bartosz I Oxid Med Cell Longev; 2020; 2020():3534570. PubMed ID: 33123310 [TBL] [Abstract][Full Text] [Related]
18. TAR DNA-binding protein 43 in neurodegenerative disease. Chen-Plotkin AS; Lee VM; Trojanowski JQ Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357 [TBL] [Abstract][Full Text] [Related]
19. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? Vanden Broeck L; Callaerts P; Dermaut B Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761 [TBL] [Abstract][Full Text] [Related]
20. [Pathology of basal ganglia in neurodegenerative diseases]. Wakabayashi K; Tanji K; Mori F Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]